Last Updated: 25/07/2017
Protecting the efficacy of antimalarial therapies by novel approaches to suppress the emergence of drug resistance
Objectives
The overall objective of the proposed project is to develop a technological platform that will enable an assessment of the potential for drug resistance emergence to inform the drug development process, including the co-development of combination therapies at an early stage in the discovery/development process.
Principal Institution
Harvard T.H. Chan School of Public Health (HSPH), United States
Principal Investigators / Focal Persons
Thematic Categories
Combination of Interventions
Drug Resistance
Enabling Technologies & Assays
Date
Dec 2015 — Oct 2017
Funding Details
Project Site